Apolipoprotein E and Alzheimer's disease;Apolipoproteine E et maladie d'Alzheimer

Sang Thrombose Vaisseaux

Volumn 10, Issue 5, 1998, Pages 281-290

  Amouyel, Philippe ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; CHOLESTEROL;

ALZHEIMER DISEASE; CHOLESTEROL METABOLISM; DEMENTIA; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; REVIEW;

EID: 0031856384     PISSN: 09997385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Dallongeville J. Apolipoprotéine E : propriétés physiologiques, polymorphisme et athérosclérose. Sang Thromb Vaiss 1998 ; 5 : 707-17.
2. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K. Apolipoprotein E immuno-reactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 1991 ; 541 : 163-6.
3. Boyles JK, Zoellner CD, Andersen LJ, et al. A role for apolipoprotein E, apolipoprotein A-I. and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest 1989 ; 83 . 1015-31.
4. Pitas RE, Boyles JK, Lee SH, Hui D, Weisgraber KH. Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. J Biol Chem 1987 ; 262 : 14352-60.
5. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E : high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993 ; 90 : 1977-81.
6. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993 ; 261 : 921-3.
7. Poirier J, Davignon J, Bouthillier D, et al. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993 ; 342 : 697-9.
8. Brousseau T, Legrain S, Berr C, et al. Confirmation of the epsilon 4 allele of the apolipoprotein E gene as a risk factor for lateonset Alzheimer's disease. Neurology 1994 ; 44 : 342-4.
9. Chartier-Harlin MC, Parfitt M, Legrain S, et al. Apolipoprotein E. ∈4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease : analysis of the 19q13.2 chromosomal region. Hum Mol Genet 1994 ; 3 : 569-74.
10. Berr C. 100 000 nouveaux cas de démence par an. La Recherche 1997 ; 303 . 68-71.
11. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease : report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984 ; 34 : 939-44.
12. Selkoe DJ. The molecular pathology of Alzheimer's disease. Neuron 1991 ; 6 : 487-98.
13. Haass C, Selkoe DJ. Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide. Cell 1993 ; 75 : 1039-42.
14. Crowther RA. Tau protein and paired helical filaments of Alzheimer's disease. Curr Opin Struct Biol 1993 ; 3 : 202-6.
15. Goate A, Chartier-Harlin MC, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991 ; 349 : 704-6.
16. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995 ; 375 : 754-60.
17. Levy-Lahad E, Wijsman EM, Nemens E, et al. A familial Alzheimer's disease locus on chromosome 1. Science 1995 ; 269 : 970-3.
18. Schellenberg GD, Deeb SS, Boehnke M, et al. Association of an apolipoprotein CII allele with familial dementia of the Alzheimer type. J Neurogenet 1987 ; 4 : 97-108.
19. Pencak-Vance MA, Bebout JL, Gaskell PCJ, et al. Linkage studies in familial Alzheimer disease : evidence for chromosome 19 linkage. Am J Hum Genet 1991 ; 48 : 1034-50.
20. Bickeboller H, Campion D, Brice A, et al. Apolipoprotein E and Alzheimer disease : genotype-specific risks by age and sex. Am J Hum Genet 1997 ; 60 : 439-46.
21. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Akheimer disease. A meta-analysis. ApoE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997 ; 278 : 1349-56.
22. Wisniewski T, Frangione B, Apolipoprotein E : a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 1992 ; 135 : 235-8.
23. Strittmatter WJ, Saunders AM, Goedert M, et al Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau : implications for Alzheimer disease. Proc Natl Acad Sci USA 1994 ; 91 : 11183-6.
24. Berr C, Hauw JJ, Delaere P, Duyckaerts C, Amouyel P, Apolipoprotein E allele ∈4 is linked to increased deposition of the amyloid beta-peptide (A-beta) in cases with or without Alzheimer's disease. Neurosci Lett 1994 ; 178 : 221-4.
25. Hardy JA, Higgins GA. Alzheimer's disease : the amyloid cascade hypothesis. Science 1992 ; 256 : 184-5.
26. Strittmatter WJ, Weisgraber KH, Goedert M, et al. Hypothesis : microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol 1994 ; 125 : 163-71.
27. Carlsson J, Armstrong VW, Reiber H, Felgenhauer K, Seidel D. Clinical relevance of the quantification of apohpoprotein E in cerebrospinal fluid. Clin Chim Acta 199l ; 196: 167-76.
28. Nathan BP, Bellosta S, Sanan DA, et al. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 1994 ; 264 : 850-2.
29. Poirier J, Delisle MC, Quirion R, et al. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Natl Acad Sci USA 1995 ; 92 : 12260-4.
30. Miyata M, Smith JD, Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet 1996 ; 14 : 55-61.
31. Barger SW, Harmon AD. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 1997 ; 388 : 878-81.
32. Amouyel P, Vidal O, Launay JM, Laplanche JL. The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. The French Research Group on Epidemiology of Human Spongiform Encephalopathies. Lancet 1994 ; 344 : 1315-8.
33. Harrington CR, Louwagie J, Rossau R, et al. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. Am J Pathol 1994 ; 145 : 1472-84.
34. Al-Chalabi A, Enayat ZE, Bakker MC, et al. Association of apolipoprotein E ∈4 allele with bulbar-onset motor neuron disease. Lancet 1996 ; 347 : 159-60.
35. Jordan BD, Relkin NR, Ravdin LD, et al. Apolipoprotein E ∈4 associated with chronic traumatic brain injury in boxing. JAMA 1997 ; 278 : 136-40.
36. Hofman A, Ott A, Breteler MM, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997 ; 349 : 151-4.
37. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994 ; 7 : 180-4.
38. Berr C, Dufouil C, Brousseau T, et al. Early effect of ApoE-∈4 allele on cognitive results in a group of highly performing subjects : the EVA study Étude sur le Vieillissement Artériel. Neurosci Lett 1996 ; 218 : 9-12.
39. Lambert JC, Perez-Tur J, Dupire MJ, et al. Distortion of allelic expression of apolipoprotein E m Alzheimer's disease. Hum Mol Genet 1997 ; 6 . 2151-4.
40. Lambert JC, Pasquier F, Cottel D, et al. A new polymorphism in the ApoE promoter associated with risk of developing Alzheimer's disease. Hum Mol Genet 1998 ; 7 : 533-40.
41. Bullido MJ, Artiga MJ, Recuero M, et al. A polymorphism in the regulatory region of ApoE associated with risk for Alzheimer's dementia. Nat Genet 1998 ; 18 : 69-71.
42. Artiga MJ, Bullido MJ, Sastre I, et al. Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. FEBS Lett 1998 ; 421 : 105-8.
43. National Institute on Aging/Alzheimer's Association Working Group. Apolipoprotein E genotyping in Alzheimer's disease. Lancet 1996 ; 347 : 1091-5.
44. Frisoni GB, Govoru S, Geroldi C, et al Gene dose of the ∈4 allek of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol 1995 ; 37 : 596-604
45. Basun H, Grut M, Winblad B, Lannfelt L. Apolipoprotein ∈4 allele and disease progression in patients with late-onset Alzheimer's disease. Neurosci Lett 1995 ; 183 : 32-4.
46. Richard F, Helbecque N, Neuman E, et al ApoE genotyping and response to drug treatment in Alzheimer's disease Lancet 1997 ; 349 : 539.
47. Schachter F, Faure-Delanef L, Guenot F, et al. Genetic associations with human longevity at the ApoE and ACE loci. Nat Genet 1994 ; 6 : 29-32.
48. Hanlon CS, Rubinsztein DC. Arginine residues at codons 112 and 158 in the apolipoprotein E gene correspond to the ancestral state in humans. Atherosclerosis 1995 ; 112 : 85-90.
49. Souied EH, Benlian P, Amouyel P. The ∈4 allele of the apolipoprotein E gene as a potential protective factor for exsudative agerelated macular degeneration. Am J Ophthalmol 1998 ; 125 : 353-9.